226 related articles for article (PubMed ID: 34275478)
1. Interleukin-10 deficiency exacerbates inflammation-induced tau pathology.
Weston LL; Jiang S; Chisholm D; Jantzie LL; Bhaskar K
J Neuroinflammation; 2021 Jul; 18(1):161. PubMed ID: 34275478
[TBL] [Abstract][Full Text] [Related]
2. Suppression of LPS-induced tau hyperphosphorylation by serum amyloid A.
Liu J; Wang D; Li SQ; Yu Y; Ye RD
J Neuroinflammation; 2016 Feb; 13():28. PubMed ID: 26838764
[TBL] [Abstract][Full Text] [Related]
3. Regulation of tau pathology by the microglial fractalkine receptor.
Bhaskar K; Konerth M; Kokiko-Cochran ON; Cardona A; Ransohoff RM; Lamb BT
Neuron; 2010 Oct; 68(1):19-31. PubMed ID: 20920788
[TBL] [Abstract][Full Text] [Related]
4. LPS- induced inflammation exacerbates phospho-tau pathology in rTg4510 mice.
Lee DC; Rizer J; Selenica ML; Reid P; Kraft C; Johnson A; Blair L; Gordon MN; Dickey CA; Morgan D
J Neuroinflammation; 2010 Sep; 7():56. PubMed ID: 20846376
[TBL] [Abstract][Full Text] [Related]
5. Genetically enhancing the expression of chemokine domain of CX
Bemiller SM; Maphis NM; Formica SV; Wilson GN; Miller CM; Xu G; Kokiko-Cochran ON; Kim KW; Jung S; Cannon JL; Crish SD; Cardona AE; Lamb BT; Bhaskar K
J Neuroinflammation; 2018 Sep; 15(1):278. PubMed ID: 30253780
[TBL] [Abstract][Full Text] [Related]
6. Short-term treadmill exercise increased tau insolubility and neuroinflammation in tauopathy model mice.
Elahi M; Motoi Y; Matsumoto SE; Hasan Z; Ishiguro K; Hattori N
Neurosci Lett; 2016 Jan; 610():207-12. PubMed ID: 26592481
[TBL] [Abstract][Full Text] [Related]
7. GSK3β is involved in promoting Alzheimer's disease pathologies following chronic systemic exposure to Porphyromonas gingivalis lipopolysaccharide in amyloid precursor protein
Jiang M; Zhang X; Yan X; Mizutani S; Kashiwazaki H; Ni J; Wu Z
Brain Behav Immun; 2021 Nov; 98():1-12. PubMed ID: 34391814
[TBL] [Abstract][Full Text] [Related]
8. Lipopolysaccharide-induced inflammation exacerbates tau pathology by a cyclin-dependent kinase 5-mediated pathway in a transgenic model of Alzheimer's disease.
Kitazawa M; Oddo S; Yamasaki TR; Green KN; LaFerla FM
J Neurosci; 2005 Sep; 25(39):8843-53. PubMed ID: 16192374
[TBL] [Abstract][Full Text] [Related]
9. ApoE4 markedly exacerbates tau-mediated neurodegeneration in a mouse model of tauopathy.
Shi Y; Yamada K; Liddelow SA; Smith ST; Zhao L; Luo W; Tsai RM; Spina S; Grinberg LT; Rojas JC; Gallardo G; Wang K; Roh J; Robinson G; Finn MB; Jiang H; Sullivan PM; Baufeld C; Wood MW; Sutphen C; McCue L; Xiong C; Del-Aguila JL; Morris JC; Cruchaga C; ; Fagan AM; Miller BL; Boxer AL; Seeley WW; Butovsky O; Barres BA; Paul SM; Holtzman DM
Nature; 2017 Sep; 549(7673):523-527. PubMed ID: 28959956
[TBL] [Abstract][Full Text] [Related]
10. Reactive microglia drive tau pathology and contribute to the spreading of pathological tau in the brain.
Maphis N; Xu G; Kokiko-Cochran ON; Jiang S; Cardona A; Ransohoff RM; Lamb BT; Bhaskar K
Brain; 2015 Jun; 138(Pt 6):1738-55. PubMed ID: 25833819
[TBL] [Abstract][Full Text] [Related]
11. Partial reduction of microglia does not affect tau pathology in aged mice.
Bennett RE; Bryant A; Hu M; Robbins AB; Hopp SC; Hyman BT
J Neuroinflammation; 2018 Nov; 15(1):311. PubMed ID: 30413160
[TBL] [Abstract][Full Text] [Related]
12. Increasing Tau 4R Tau Levels Exacerbates Hippocampal Tau Hyperphosphorylation in the hTau Model of Tauopathy but Also Tau Dephosphorylation Following Acute Systemic Inflammation.
Barron MR; Gartlon J; Dawson LA; Atkinson PJ; Pardon MC
Front Immunol; 2020; 11():293. PubMed ID: 32194553
[TBL] [Abstract][Full Text] [Related]
13. Sulforaphene Ameliorates Neuroinflammation and Hyperphosphorylated Tau Protein via Regulating the PI3K/Akt/GSK-3
Yang W; Liu Y; Xu QQ; Xian YF; Lin ZX
Oxid Med Cell Longev; 2020; 2020():4754195. PubMed ID: 32963694
[TBL] [Abstract][Full Text] [Related]
14. Microglial activation arises after aggregation of phosphorylated-tau in a neuron-specific P301S tauopathy mouse model.
van Olst L; Verhaege D; Franssen M; Kamermans A; Roucourt B; Carmans S; Ytebrouck E; van der Pol SMA; Wever D; Popovic M; Vandenbroucke RE; Sobrino T; Schouten M; de Vries HE
Neurobiol Aging; 2020 May; 89():89-98. PubMed ID: 32008854
[TBL] [Abstract][Full Text] [Related]
15. CCL2 Overexpression in the Brain Promotes Glial Activation and Accelerates Tau Pathology in a Mouse Model of Tauopathy.
Joly-Amado A; Hunter J; Quadri Z; Zamudio F; Rocha-Rangel PV; Chan D; Kesarwani A; Nash K; Lee DC; Morgan D; Gordon MN; Selenica MB
Front Immunol; 2020; 11():997. PubMed ID: 32508844
[TBL] [Abstract][Full Text] [Related]
16. Selective suppression of the α isoform of p38 MAPK rescues late-stage tau pathology.
Maphis N; Jiang S; Xu G; Kokiko-Cochran ON; Roy SM; Van Eldik LJ; Watterson DM; Lamb BT; Bhaskar K
Alzheimers Res Ther; 2016 Dec; 8(1):54. PubMed ID: 27974048
[TBL] [Abstract][Full Text] [Related]
17. Alpha1-antichymotrypsin, an inflammatory protein overexpressed in Alzheimer's disease brain, induces tau phosphorylation in neurons.
Padmanabhan J; Levy M; Dickson DW; Potter H
Brain; 2006 Nov; 129(Pt 11):3020-34. PubMed ID: 16987932
[TBL] [Abstract][Full Text] [Related]
18. Interleukin 10 Restores Lipopolysaccharide-Induced Alterations in Synaptic Plasticity Probed by Repetitive Magnetic Stimulation.
Lenz M; Eichler A; Kruse P; Strehl A; Rodriguez-Rozada S; Goren I; Yogev N; Frank S; Waisman A; Deller T; Jung S; Maggio N; Vlachos A
Front Immunol; 2020; 11():614509. PubMed ID: 33391287
[TBL] [Abstract][Full Text] [Related]
19. TREM2 modifies microglial phenotype and provides neuroprotection in P301S tau transgenic mice.
Jiang T; Zhang YD; Chen Q; Gao Q; Zhu XC; Zhou JS; Shi JQ; Lu H; Tan L; Yu JT
Neuropharmacology; 2016 Jun; 105():196-206. PubMed ID: 26802771
[TBL] [Abstract][Full Text] [Related]
20. Kinesin-1 transport reductions enhance human tau hyperphosphorylation, aggregation and neurodegeneration in animal models of tauopathies.
Falzone TL; Gunawardena S; McCleary D; Reis GF; Goldstein LS
Hum Mol Genet; 2010 Nov; 19(22):4399-408. PubMed ID: 20817925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
